10.23
전일 마감가:
$9.87
열려 있는:
$9.73
하루 거래량:
1.89M
Relative Volume:
1.50
시가총액:
$1.59B
수익:
$363.55M
순이익/손실:
$-78.68M
주가수익비율:
-20.46
EPS:
-0.5
순현금흐름:
$50.74M
1주 성능:
+0.79%
1개월 성능:
-14.61%
6개월 성능:
-10.03%
1년 성능:
-39.65%
Certara Inc Stock (CERT) Company Profile
명칭
Certara Inc
전화
(415) 237-8272
주소
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
CERT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CERT
Certara Inc
|
10.23 | 1.59B | 363.55M | -78.68M | 50.74M | -0.50 |
![]()
VEEV
Veeva Systems Inc
|
226.50 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
57.95 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
49.89 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
88.74 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.33 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-27 | 개시 | TD Cowen | Buy |
2024-09-27 | 업그레이드 | UBS | Neutral → Buy |
2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-04-04 | 개시 | JMP Securities | Mkt Perform |
2024-02-26 | 개시 | Leerink Partners | Market Perform |
2023-12-07 | 개시 | UBS | Neutral |
2023-12-05 | 개시 | KeyBanc Capital Markets | Sector Weight |
2023-08-22 | 다운그레이드 | Jefferies | Buy → Hold |
2023-08-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2023-04-12 | 개시 | Stephens | Overweight |
2023-04-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2022-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2022-09-08 | 개시 | Berenberg | Buy |
2022-08-25 | 개시 | Credit Suisse | Outperform |
2022-07-01 | 개시 | Piper Sandler | Overweight |
2022-01-11 | 업그레이드 | Jefferies | Hold → Buy |
2021-08-05 | 재개 | Credit Suisse | Neutral |
2021-07-23 | 개시 | Robert W. Baird | Outperform |
2021-03-03 | 개시 | Barclays | Overweight |
2021-01-06 | 개시 | Morgan Stanley | Equal-Weight |
2021-01-05 | 개시 | BofA Securities | Buy |
2021-01-05 | 개시 | Credit Suisse | Neutral |
2021-01-05 | 개시 | Jefferies | Hold |
2021-01-05 | 개시 | William Blair | Outperform |
모두보기
Certara Inc 주식(CERT)의 최신 뉴스
Checking Back In On Certara: Unattractive Valuation (NASDAQ:CERT) - Seeking Alpha
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities - The Manila Times
Certara unveils advanced drug development simulator - Investing.com
Revolutionary AI Update: How Certara's New Simcyp Platform is Transforming Drug Development - Stock Titan
Proficio Capital Partners LLC Buys Shares of 13,856 Certara, Inc. (NASDAQ:CERT) - Defense World
Why Certara, Inc. (NASDAQ:CERT) Could Be Worth Watching - simplywall.st
At US$9.91, Is Certara, Inc. (NASDAQ:CERT) Worth Looking At Closely? - Yahoo Finance
Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 - MSN
Certara Inc.: Is The Biosimulation & Software Growth Here To Stay? - Smartkarma
Commit To Buy Certara At $7.50, Earn 14.3% Annualized Using Options - Nasdaq
Raymond James Financial Inc. Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Receives $15.83 Consensus Price Target from Brokerages - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Purchased by HighTower Advisors LLC - Defense World
Avantax Advisory Services Inc. Sells 17,660 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Charles Schwab Investment Management Inc. Grows Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
PNC Financial Services Group Inc. Raises Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Amundi Raises Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Atria Investments Inc Reduces Position in Certara, Inc. (NASDAQ:CERT) - Defense World
US Bancorp DE Has $101,000 Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
(CERT) Technical Data - news.stocktradersdaily.com
Proficio Capital Partners LLC Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges By Investing.com - Investing.com South Africa
Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges - Investing.com Australia
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation - Investing.com India
Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation By Investing.com - Investing.com South Africa
Certara Inc (NASDAQ: CERT) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register
Bank of New York Mellon Corp Purchases 1,253,385 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
23,568 Shares in Certara, Inc. (NASDAQ:CERT) Acquired by Private Advisor Group LLC - Defense World
Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - citybiz
Certara announces leadership change in drug development By Investing.com - Investing.com South Africa
Certara announces leadership change in drug development - Investing.com India
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 05:07 pm EST - Marketscreener.com
Certara Announces Leadership Change with Dr. Smith’s Departure - TipRanks
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:16 pm EST - Marketscreener.com
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:15 pm EST - Marketscreener.com
Can This Former IQVIA Executive Transform Certara's Drug Development Approach? - StockTitan
Principal Financial Group Inc. Has $5.66 Million Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Objective long/short (CERT) Report - Stock Traders Daily
Q2 Earnings Estimate for Certara Issued By William Blair - Defense World
Certara (NASDAQ:CERT) Price Target Raised to $13.00 - Defense World
Q1 Earnings Estimate for Certara Issued By Leerink Partnrs - Defense World
Rhumbline Advisers Has $2.96 Million Stock Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Brokerages Set Certara, Inc. (NASDAQ:CERT) Price Target at $15.42 - Defense World
KeyBanc maintains Overweight rating on Certara shares with $15 target - Investing.com India
KeyBanc maintains Overweight rating on Certara shares with $15 target By Investing.com - Investing.com South Africa
Certara Inc (CERT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Certara Inc 주식 (CERT) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS |
Oct 04 '24 |
Option Exercise |
0.00 |
7,151 |
0 |
57,242 |
자본화:
|
볼륨(24시간):